Researchers, companies and Wall Street are gathering to gain a sense of bringing potentially multibillion dollar drugs to market.» Read More
Resonant Inc. rose 37.3 percent to $7.03. Susquehanna Bancshares Inc. rose 32.5 percent to $13.12. Caesars Entertainment Corp. rose 22.7 percent to $13.67.
Achillion Pharmaceuticals Inc. rose 1.5 percent to $13.04 with 9,164,000 shares traded. Apple Inc. was unchanged at $108.84 with 13,261,900 shares traded. BlackBerry Ltd. fell. 3 percent to $11.06 with 8,730,100 shares traded.
Nov 11- AbbVie Inc said its experimental drug that treats genotype 4 hepatitis C showed high response rates in a mid-stage study in patients who have been considered difficult to treat. AbbVie said on Tuesday 100 percent of the patients who were given the drug and had failed previous treatment showed high response rates at 12 weeks after the treatment.
NEW YORK— Shares of Achillion Pharmaceuticals climbed Monday after the company reported clinical trial results for one of its experimental hepatitis C drugs. Achillion said all 12 patients who were treated with its drug ACH-3102 and Sovaldi, a blockbuster medication sold by Gilead Sciences Inc., had undetectable levels of the hepatitis C virus after eight...
Orexigen Therapeutics Inc. rose 33.2 percent to $5.13. Achillion Pharmaceuticals Inc. rose 27.1 percent to $12.85. Planar Systems Inc. rose 20.0 percent to $7.68.
Achillion Pharmaceuticals Inc. rose 27.1 percent to $12.85 with 28,357,100 shares traded. American Realty Capital Properties Inc. fell 3.3 percent to $8.50 with 24,314,500 shares traded. Apple Inc. fell. 2 percent to $108.83 with 26,654,700 shares traded.
*Best Buy tumbles after results, DSW higher. *Digital Ally gains again, has tripled this month. "People aren't going to do anything too aggressive until there's some kind of catalyst, either positive or negative, and we may end up consolidating around 2,000 for a while," said Michael O'Rourke, chief market strategist at JonesTrading in Greenwich, Connecticut.
*Best Buy tumbles after results, DSW higher. *Digital Ally gains before bell, has tripled this month. Nonetheless, further gains may be a challenge without positive catalysts and amid potential headwinds such as a reduction in Federal Reserve stimulus and a simmering conflict between Ukraine and Russia.
*Digital Ally gains before bell, has tripled this month. NEW YORK, Aug 26- U.S. stock index futures were little changed on Tuesday, with investors finding few reasons to buy after a rally in the previous session that took the S&P 500 above 2,000 for the first time.
Take a look at some of Friday's midday movers:
Aug 15- Achillion Pharmaceuticals Inc said all patients treated with its experimental hepatitis C drug showed no detectable levels of the virus four weeks after the therapy, sending its shares up 18 percent. Achievement of 100 percent cure rate confirms the competitive profile of NS5A, Wells Fargo Securities analyst Brian Abrahams wrote in a note.
Aug 15- Achillion Pharmaceuticals Inc said interim results from a mid-stage trial showed that all patients given its experimental hepatitis C drug showed no detectable levels of the virus four weeks after completing the therapy.
Take a look at some of Monday's midday movers:
Some of Monday's midday movers:
*S&P 500 breaks string of record high closes. *Achillion Pharmaceuticals soars in heavy volume. NEW YORK, June 10- U.S. stocks finished nearly flat on Tuesday, although the Dow eked out another record closing high as utilities' shares fell while 10- year bond yields hit their highest level in a month.
*Achillion Pharmaceuticals jumps in heavy volume. Facebook Inc rose 4.3 percent to $65.59. Netflix Inc gained 1.4 percent to $429.11.
Achillion's been a takeover target for years. But Merck's acquisition of Idenix may mean Achillion's time has come.
Some of Tuesday's midday movers:
NEW YORK, June 10- U.S. stocks fell modestly on Tuesday as investors found few reasons to keep buying with the Dow and S&P 500 coming off a string of record highs. Facebook Inc rose 3.5 percent to $65.05 while Netflix Inc was up 2.7 percent to $434.51. Tuesday's decline comes after a string of gains for Wall Street.
NEW YORK, June 10- U.S. stocks fell modestly on Tuesday as investors found few reasons to keep buying with the Dow and S&P 500 coming off a string of record highs. Facebook Inc rose 2.6 percent to $64.50 while Netflix Inc was up 2.3 percent to $432.94. Tuesday's decline comes after a string of gains for Wall Street.